T. Rowe Price Associates
URGN icon

T. Rowe Price Associates’s UroGen Pharma URGN Stock Holding History

T. Rowe Price Associates’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$512K Sell
28,454
-588,152
-95% -$11.8M ﹤0.01% 2449
2025
Q4 		$14.4M Buy
616,606
+259,991
+73% +$5.64M ﹤0.01% 1149
2025
Q3 		$7.12M Sell
356,615
-4,826
-1% -$86.7K ﹤0.01% 1308
2025
Q2 		$4.95M Sell
361,441
-7,213
-2% -$69.2K ﹤0.01% 1267
2025
Q1 		$4.08M Sell
368,654
-25,330
-6% -$270K ﹤0.01% 1308
2024
Q4 		$4.2M Buy
393,984
+381,145
+2,969% +$4.56M ﹤0.01% 1332
2024
Q3 		$164K Buy
12,839
+1,891
+17% +$28.1K ﹤0.01% 2714
2024
Q2 		$184K Sell
10,948
-256,195
-96% -$3.64M ﹤0.01% 2611
2024
Q1 		$4.01M Buy
+267,143
New +$4.37M ﹤0.01% 1282

Other funds holding URGN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $51.9B AUM 40.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
JFG
Jefferies Financial Group New York $8.2B AUM 40.95% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $90.6B AUM 36.98% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return